Deltakelse i radio eller TV

• Anne Kristine Lehmann (1997). Presentasjon av ny metode for utvelgelse av komponenter til meningokokkvaksine. (ekstern lenke)

Doktorgradsavhandling

• Anne Kristine Lehmann (2000). Antigen-specific opsonophagocytosis : functional assays to identify meningococcal candidates. (ekstern lenke)

Forelesning

• Anne Kristine Lehmann (1997). Infeksjonsforsvaret ved meningokokksykdom. (ekstern lenke)
• Anne Kristine Lehmann (1997). Quantitation of antigen-specific, opsonin-dependent phagocytosis and oxidative burst responses. (ekstern lenke)
• Anne Kristine Lehmann (1997). Meningokokksykdom - utvelgelse av vaksineantigener. (ekstern lenke)
• Anne Kristine Lehmann; Alfred Halstensen (1996). Gamle bakterier i endret drakt. (ekstern lenke)
• Anne Kristine Lehmann (1996). Meningokokksykdom - ny metode for utvelgelse av vaksineantigener. Kurs nr. B 1220: Molekylær immunologi. (ekstern lenke)
• Anne Kristine Lehmann (1996). Presentasjon av data fra undersøkelse av halsprøver tatt i forbindelse med utbrudd av meningokokksykdom i Nordhordland. (ekstern lenke)
• Anne Kristine Lehmann; Alfred Halstensen; Carl-Fredrik Bassøe (1996). Ny metode for utvelgelse av opsonininduserende meningokokkantigener. (ekstern lenke)
• Anne Kristine Lehmann (1996). Presentasjon av data fra undersøkelse av halsprøver tatt i forbindelse med utbrudd av meningokokksykdom i Nordhordland. (ekstern lenke)
• Anne Kristine Lehmann (1996). Carriage eradication with single-dose ofloxacin during an outbreak of meningococcal disease caused by a new pathogenic strain in Norway. (ekstern lenke)

Konferanseabstrakt

• Kolstad Arne; Anna Laurell; Mats Jerkeman et al. (2012). Nordic MCL3 Study: Zevalin Combined with High-Dose Chemotherapy Followed by Autologous Stem Cell Support As Late Intensification for Mantle Cell Lymphoma (MCL) Patients < 66 Years Not in CR After Induction Chemoimmunotherapy: No Benefit of Zevalin. (ekstern lenke)
• Arne Kolstad; Anna Laurell; Niels S. Andersen et al. (2009). (90)y-Ibritumumab Tiuxetan (Zevalin (R))-BEAM/C with Autologous Stem Cell Support as Frontline Therapy for Advanced Mantle Cell Lymphoma.- Preliminary Results From the Third Nordic MCL Phase II Study (MCL3). (ekstern lenke)

Konferanseforedrag

• Ingrid Smith; Anne Kristine Lehmann; L. Lie et al. (1998). Meningococcal disease outbreak due to a new strain C:15:P1.7,16 in Western Norway, and selective carriage eradication of this strain. (ekstern lenke)
• J. S. Plested; B.F. Ferry; Anne Kristine Lehmann et al. (1998). Functional studies of antibodies to inner core lipopolysaccharide (LPS) of Neisseria meningitidis (Nm) group B, using a flow cytometric-based opsonophagocytosis assay. (ekstern lenke)
• Anne Kristine Lehmann; Hilde-Kari Guttormsen; L.M. Wetzler et al. (1998). Patient opsonins against specific meningococcal outer membrane components. (ekstern lenke)
• A.R. Gorringe; Anne Kristine Lehmann; K. Reddin et al. (1998). Characterisation of human antibody responses to meningococcal transferrin-binding proteins and evaluation of antigen-specific opsonophagocytosis. (ekstern lenke)
• J.S. Plested; B.F. Ferry; Anne Kristine Lehmann et al. (1998). A flow cytometric based opsonophagocytosis assay to study the role of complement and antigen-specific antibody in the uptake of Neisseria meningiti by human peripheral blood monocytes and granulocytes. (ekstern lenke)
• A.R. Gorringe; I.C. Boulton; K.M. Reddin et al. (1997). Meningococcal transferrin binding proteins: function and vaccine potential. (ekstern lenke)
• E. Rosenqvist; G. Bjune; O. Closs et al. (1996). Effect of aluminium hydroxide adjuvant and serogroup C polysaccharide on the immunogenicity and reactogenicity of a group B Neisseria meningitidis outer membrane vesicle vaccine. (ekstern lenke)
• Anne Kristine Lehmann (1996). Carriage eradication with single-dose Ofloxacin during an outbreak of meningococcal disease caused by a new epidemic strain in Western Norway. (ekstern lenke)
• Anne Kristine Lehmann; Alfred Halstensen; Steinar Sørnes et al. (1996). High levels of interleukin 10 in serum are associated with fatality in meningococcal disease. (ekstern lenke)
• Anne Kristine Lehmann; Alfred Halstensen; J. Holst et al. (1996). Opsonophagocytosis responses to meningococcal antigens adsorbed to beads. (ekstern lenke)
• P Raboisson; K Flood; Anne Kristine Lehmann et al. (1996). Species differences in vacuolization of cortical neurons after administration of the NMDA receptor antagonist dizocilipine. (ekstern lenke)

Konferanseposter

• Sonia Gavasso; Jonas Bull Haugsøen; Dimitrios Kleftogiannis et al. (2024). Short-Term and Long-Term Impact of Autologous Haematopoietic Stem Cell Transplantation on Immune Profiles in Relapsing-Remitting Multiple Sclerosis. (ekstern lenke)
• K. S. Thunold; Wenke Trovik; Steinar Sørnes et al. (1996). Routine Quantitation of phagocytosis by flow cytometry. (ekstern lenke)

Leserbrev

• Ellen Berget; Lars Helgeland; Anne Kristine Lehmann et al. (2013). Primary diffuse large B-cell lymphoma of the dura without systemic recurrence four years after diagnosis and successful therapy. (ekstern lenke)

Populærvitenskapelig artikkel

• Anne Kristine Lehmann (1997). Meningokokk B. Jakten på ny vaksine mot hjernehinnebetennelse. Hva er meningokokksykdom? [Intervju og informasjon]. (ekstern lenke)

Vitenskapelig artikkel

• Tomas Kalincik; Sifat Sharmin; Izanne Roos et al. (2026). Haematopoietic stem cell transplant versus immune-reconstitution therapy in relapsing multiple sclerosis. (ekstern lenke)
• Sonia Gavasso; Jonas Bull Haugsøen; Dimitrios Kleftogiannis et al. (2025). High-dimensional Immune Profiling Following Autologous Hematopoietic Stem Cell Transplantation in Relapsing-Remitting Multiple Sclerosis. (ekstern lenke)
• Katharina Natalie Gottschlich; Zinajda Zolic-Karlsson; Eline Aas et al. (2024). Healthcare utilization and costs associated with autologous haematopoietic stem cell transplantation in Norwegian patients with relapsing remitting multiple sclerosis. (ekstern lenke)
• Tomas Kalincik; Sifat Sharmin; Izanne Roos et al. (2024). Effectiveness of autologous haematopoietic stem cell transplantation versus natalizumab in progressive multiple sclerosis. (ekstern lenke)
• Christopher Elnan Kvistad; Anne Kristine Lehmann; Silje Agnethe Stokke et al. (2024). Autologous hematopoietic stem cell transplantation for multiple sclerosis: Long-term follow-up data from Norway. (ekstern lenke)
• Tomas Kalincik; Sifat Sharmin; Izanne Roos et al. (2023). Comparative Effectiveness of Autologous Hematopoietic Stem Cell Transplant vs Fingolimod, Natalizumab, and Ocrelizumab in Highly Active Relapsing-Remitting Multiple Sclerosis. (ekstern lenke)
• Silje Agnethe Stokke; Joachim Burman; Anne Kristine Lehmann et al. (2022). Impact of previous disease-modifying treatment on safety and efficacy in patients with MS treated with AHSCT. (ekstern lenke)
• Line Stensig Lynggaard; Goda Vaitkeviciene; Cecilia Langenskiöld et al. (2022). Asparaginase encapsulated in erythrocytes as second-line treatment in hypersensitive patients with acute lymphoblastic leukaemia. (ekstern lenke)
• Silje Agnethe Stokke; Anne Kristine Lehmann; Linn Trovik et al. (2019). Safety and efficacy of autologous hematopoietic stem cell transplantation for multiple sclerosis in Norway. (ekstern lenke)
• Dag Torfoss; Tone Fladhagen; Harald Holte et al. (2016). Benzylpenicillin plus an aminoglycoside versus meropenem in neutropenic lymphoma and leukaemia patients with a suspected bacterial infection: a randomized, controlled trial. (ekstern lenke)
• Arne Kolstad; Anna Laurell; Mats Jerkeman et al. (2014). Nordic MCL3 study: 90Y-ibritumomab-tiuxetan added to BEAM/C in non-CR patients before transplant in mantle cell lymphoma. (ekstern lenke)
• Anne Kristine Lehmann; Steinar Sørnes; Alfred Halstensen (2000). Phagocytosis: measurement by flow cytometry. (ekstern lenke)
• Carl-Fredrik Bassøe; Ingrid Smith; Steinar Sørnes et al. (2000). Concurrent measurement of antigen- and antibody dependent oxidative burst and phagocytosis in monocytes and neutrophils. (ekstern lenke)
• Ingrid Smith; Anne Kristine Lehmann; L Lie et al. (1999). Outbreak of meningococcal disease in western Norway due to a new serogroup C variant of the ET-5 clone: effect of vaccination and selective carriage eradication. (ekstern lenke)
• Anne Kristine Lehmann; A.R. Gorringe; KM Reddin et al. (1999). Human opsonins induced during mengococcal disease recognize transferrin binding protein complexes. (ekstern lenke)
• Anne Kristine Lehmann; Alfred Halstensen; I.S. Aaberge et al. (1999). Human opsonins induced during mengococcal disease recognise outer membrane proteins PorA and PorB. (ekstern lenke)
• E. Rosenqvist; E. A. Høiby; Gunnar Bjune et al. (1998). Effect of aluminium hydroxide adjuvant and serogroup C polysaccharide on the immunogenicity and reactogenicity of a group B Neisseria meningitidis outer membrane vesicle vaccine. (ekstern lenke)
• Anne Kristine Lehmann; Alfred Halstensen; Carl-Fredrik Bassøe (1998). Flow cytometric quantitation of human opsonin-dependent phagocytosis and oxidative burst responses to meningococcal antigens. (ekstern lenke)
• E. Rosenqvist; E. A. Høiby; Gunnar Bjune et al. (1998). Effect of aluminium hydroxide and meningococcal serogroup C capsular polysaccharide on the immunogenicity and reactogenicity of a group B Neisseria meningitidis outer membrane vesicle vaccine. (ekstern lenke)
• Anne Kristine Lehmann; Alfred Halstensen; J. Holst et al. (1997). Functional assays for evaluation of serogroup B meningococcal structures as mediators of human opsonophagocytosis. (ekstern lenke)
• Ola Røkke; G. Sveen; Anne Kristine Lehmann et al. (1996). Endotoxin and cytokines in plasma and clinical manifestations during treatment of septicaemia with imipenem or cefuroxime/metronidazole. (ekstern lenke)
• Ola Røkke; Gunhild Sveen; Anne Kristine Lehmann et al. (1996). Endotoxin and cytokines in plasma and clinical manifestations during treatment of septicaemia with Imipenem or Cefuroxime/Metronidazole. (ekstern lenke)
• Ola Røkke; G Sveen; Anne Kristine Lehmann et al. (1996). Endotoxin and cytokines in plasma and clinical evaluation during treatment of septicemia with imipenem or cefuroxim/metronidazol. (ekstern lenke)
• Anne Kristine Lehmann; Alfred Halstensen; A Sørnes et al. (1995). High levels of Interleukin 10 in serum are associated with fatality in meningococcal disease. (ekstern lenke)
• Anne Kristine Lehmann; R. Bjugn; O. Engebråten et al. (1992). Studentforskernes arbeidssituasjon - medisinstudenter og forskning. (ekstern lenke)
• Anne Kristine Lehmann; E. Hexeberg; O. Engebråten et al. (1992). Forskningsinteresse og rekrutteringspotensiale - medisinstudenter og forskning. (ekstern lenke)
• Anne Kristine Lehmann; Alfred Halstensen; A. Næss et al. (1991). Opsonin response in vaccinees as measured by chemiluminesence. (ekstern lenke)
• Alfred Halstensen; Anne Kristine Lehmann; Hilde-Kari Guttormsen et al. (1991). Serum opsonins to serogroup B meningococci after vaccination. (ekstern lenke)
• Anne Kristine Lehmann; Alfred Halstensen; A. Næss et al. (1991). Immunization against serogroup B meningococci. Opsonin response in vaccinees as measured by chemiluminescence. (ekstern lenke)

Vitenskapelig bokkapittel

• E. Rosenqvist; E. A. Høiby; G. Bjune et al. (1997). Effect of aluminium hydroxide adjuvant and serogroup C polysaccharide on the immunogenicity and reactogenicity of a group B <I>Neisseria meningidis</I> outer membrane vesicle vaccine. (ekstern lenke)
• Anne Kristine Lehmann; Alfred Halstensen; Steinar Sørnes et al. (1996). High levels of interleukin 10 are associated with fatality in meningococcal disease. (ekstern lenke)

Se en fullstendig oversikt over publikasjoner i NVA.